US 10442846
Hepcidin analogues and uses thereof
granted A61KA61K38/00A61P
Quick answer
US patent 10442846 (Hepcidin analogues and uses thereof) held by Protagonist Therapeutics, Inc. expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Protagonist Therapeutics, Inc.
- Grant date
- Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K38/00, A61P, A61P3/00, A61P3/12